Press Releases

Press Releases

Tonix Pharmaceuticals Holding Corp., which is developing next-generation medicines for fibromyalgia and post-traumatic stress disorder (PTSD), announced today that the first patient has been randomized in RE-AFFIRM, the second Phase 3 clinical study of TNX-102 SL (cyclobenzaprine HCl sublingual tablets), 2.8 mg, in fibromyalgia. Seth Lederman, M.D., president and chief…

Press Releases

Allergan plc, a leading global pharmaceutical company, today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a Positive Opinion for TRUBERZI® (eluxadoline) in the European Union.4 TRUBERZI® is an oral medication that relieves the main symptoms of irritable bowel syndrome with diarrhoea (IBS-D) in adults.1…

Press Releases

Eagle Pharmaceuticals, Inc. announced today that the Company will release its 2016 second quarter financial results on Tuesday, August 9, 2016, before the market opens. Scott Tarriff, President and Chief Executive Officer, and David E. Riggs, Chief Financial Officer, will host a conference call to discuss the results as follows:…

Press Releases

Several physicians recognized for their contributions to clinical research and advances in the treatment of people with Alzheimer's disease today called for immediate changes to how healthcare professionals approach the management of the disease. Citing statistics that show a lack of diagnosis and use of currently available prescription medicine proven…

Press Releases

Tobira Therapeutics, Inc. today announced that it will hold a teleconference and webcast at 8:30 a.m. Eastern Time tomorrow, Monday, July 25 to discuss Phase 2b results for cenicriviroc in patients with non-alcoholic steatohepatitis (NASH) and liver fibrosis. Teleconference/Webcast Details Listen via Internet: http://ir.tobiratx.com/ Toll-free: 1 (855) 638-8858 International: +1…

Press Releases

On June 29, 2016, Peter Marchesini, Chief Operating Officer of Alamo Pharma Services®, participated in CBI's Second Annual Life Sciences Product Launch Summit in Philadelphia. The "Ask the Experts" topic was titled "Learn from Recent Pitfalls to Prepare for Future Product Launches." They thoroughly analyzed recent product launches and discussed…

Press Releases

Chugai Pharmaceutical Co., Ltd. and Galderma Pharma S.A. today announced that they have entered into a global license agreement for “nemolizumab” (CIM331) the anti-IL-31 receptor A humanized monoclonal antibody created by Chugai, which is currently under development for atopic dermatitis and pruritus in hemodialysis patients. “This agreement highlights the great…

Press Releases

Perrigo Company plc, a leading global provider of Quality Affordable Healthcare Products®, today announced the departure of Douglas Boothe, Executive Vice President and General Manager, Rx Pharmaceuticals. John Wesolowski, Senior Vice President of Rx Commercial Operations, will assume the role of Acting General Manager, Rx Pharmaceuticals. Perrigo's Chief Executive Officer…

Press Releases

Have you seen the finalagenda for our 3rd Annual Drug Discovery USA Congress? Our expert panel of speakers will address the current strategies for directed discovery, including the resurgence of phenotypic screening and comparing its utility with target based discovery. They will explore novel peptide drug discovery, strategies for target…

Press Releases

Have you seen the latest agenda for this year’s Cell Culture & Bioprocessing Congress? Now entering its fifth year, this leading biologics event features experts at the forefront of the field from across Europe and the US, including speakers from Sanofi Pasteur, Biogen, BoehringerIngelheim,Novartis, Merck and more! PROGRAMME & SPEAKERS…